Insights

We’re acknowledged for our strong market insight and technical know-how

Life sciences
Insights

A divergent path: medical devices regulation and the Medicines and Medical Devices Act 2021

21 April 2021
Read more
News

Penningtons Manches Cooper acts for Stanford Capital and SI Capital on £1.145 million fundraising

31 March 2021
Read more
Insights

Is your science park MEES-ready?

25 February 2021
Read more
Insights

Penningtons Manches Cooper boosts growing Birmingham office with leading intellectual property lawyer

19 October 2020
Read more
News

Penningtons Manches Cooper acts for SkinBioTherapeutics plc on conditional £4.5 million equity fundraising

15 October 2020
Read more
Insights

Corporate team advises Oxford start-ups on special pandemic investment

23 September 2020
Read more
Insights

Regeneron v Kymab: UK Supreme Court rules against Regeneron in landmark patent claim sufficiency judgment

8 September 2020
Read more
News

The European Commission postpones Medical Devices Regulation

3 July 2020
Read more
Insights

Penningtons Manches Cooper advises high profile venture capital firm on investment in Cambridge-based animal health start-up

21 May 2020
Read more
Insights

The future of medicinal cannabis: patient need v public policy and regulation

21 February 2020
Read more
Insights

New guidance on the classification of software as medical devices

21 February 2020
Read more
Insights

Shanks v Unilever: an increase in employee compensation claims?

21 February 2020
Read more
Back to Life sciences